Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: May 5, 2025
Reporting Period: This filing serves as a notice for the Ordinary and Extraordinary General Shareholders' Meetings scheduled for May 28, 2025. It does not cover a specific financial reporting period (e.g., quarterly or annual results) but rather announces the upcoming shareholder event.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are disclosed in this text. The filing focuses solely on the logistics of the upcoming shareholder meetings.
Guidance, Outlook, and Management Commentary
Shareholder Meetings: The Company is convening Ordinary and Extraordinary General Shareholders' Meetings on Wednesday, May 28, 2025, at 3:00 p.m. Belgian time.
Location: The meetings will be held at the offices of notary public Stijn Raes, Kortrijksesteenweg 1147, 9051 Ghent, Belgium, or at another location as indicated at the time.
Exhibit 99.1: The filing references an attached "Combined Report of the Board of Directors on the Consolidated and (non-consolidated) Statutory Financial Statements." However, the content of this report is not included in the provided text, and the filing explicitly states that the attached information is furnished but not "filed" for purposes of Section 18 of the Exchange Act.
Important Facts for Investors to Verify
- Verify the content of Exhibit 99.1 (Combined Report of the Board of Directors) to obtain actual financial statements and management commentary, as they are not present in this summary text.
- Confirm the agenda and specific resolutions to be voted on at the Ordinary and Extraordinary General Shareholders' Meetings on May 28, 2025.
- Note that the information furnished in this filing is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934, limiting its legal liability status compared to standard financial reports.